Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2007; 13(36): 4891-4896
Published online Sep 28, 2007. doi: 10.3748/wjg.v13.i36.4891
Published online Sep 28, 2007. doi: 10.3748/wjg.v13.i36.4891
Table 2 Comparative analysis of lesion detection for 133 lesions in 59 patients using pre-contrast, ferucarbotran-enhanced, and Gd-DTPA-enhanced sequences
| Sequence | n (%) | ||
| < 1 cm | 1-3 cm | > 3 cm | |
| (n = 44 ) | (n = 68) | (n = 21 ) | |
| 1 Pre-contrast T1WI GRE | 15 (34.1)b | 48 (70.6)b | 21 (100.0) |
| 2 Pre-contrast FSE T2WI with fat suppression | 24 (54.5)b | 61 (89.7) | 21 (100.0) |
| 3 Dynamic Gd-DTPA- enhanced T1WI GRE | 35 (79.5)a | 67 (98.5) | 21 (100.0) |
| 4 Dynamic ferucarbotran- enhanced T1WI GRE | 32 (72.7) | 62 (91.2) | 21 (100.0) |
| 5 Delayed ferucarbotran-enhanced FSE T2WI with fat suppression | 41 (93.2) | 68 (100) | 21 (100.0) |
| 6 Delayed ferucarbotran- enhanced GRE T2*WI | 39 (88.6) | 67 (98.5) | 21 (100.0) |
-
Citation: Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran
versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 - URL: https://www.wjgnet.com/1007-9327/full/v13/i36/4891.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i36.4891